Ono Pharma Drug Acquired in $2.4B Deal Wins FDA Approval for Treating Rare Type of Tumor
An Ono Pharma drug for a type of tumor affecting tissues of the joints is now FDA approved, giving the ...
An Ono Pharma drug for a type of tumor affecting tissues of the joints is now FDA approved, giving the ...
SAN FRANCISCO — Cytokinetics CEO Robert Blum is very clear. The company — on track to secure U.S. approval in September ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.